Array BioPharma To Present At The Cantor Fitzgerald 2015 Healthcare Conference

Article Stock Quotes (1)

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 4/23/2024

1. TSLA
2. SPY
3. GM
4. SPOT
5. AMZN

6. SHW
7. AAPL
8. IBM
9. MINN
10. NVDA

Get Alerts ARRY Hot Sheet

Price: $11.94 +2.14%

Overall Analyst Rating:
BUY (= Flat)

EPS Growth %: -116.0%

Join SI Premium – FREE

BOULDER, Colo., July 6, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Cantor Fitzgerald 2015 Healthcare Conference in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.

Event:	Cantor Fitzgerald 2015 Healthcare Conference
Presenter:	Ron Squarer, Chief Executive Officer
Date:	Wednesday, July 8, 2015
Time:	1:00 p.m. Eastern Time
Webcast:	www.arraybiopharma.com

About Array BioPharma Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six Phase 3 studies are currently advancing. These programs include three cancer drugs, binimetinib (MEK162 / wholly-owned), encorafenib (LGX818 / wholly-owned) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.